← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2016Last known activity
Aug 31, 2018
Acquired by Lundbeck on May 6, 2019
Timeline
2010s
- Jun 1, 2011
Abide Therapeutics— Founded
- May 6, 2019
Lundbeck— Acquired By
Drugs by trial phase (1 distinct, 6 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT03625453Study directorPhase 2Aug 31, 2018
- NCT03625453Lead sponsorPhase 2Aug 31, 2018
- NCT03447756Lead sponsorPhase 1Oct 2, 2017
- NCT03138421Lead sponsorPhase 1May 1, 2017
- NCT03058562Lead sponsorPhase 1Feb 1, 2017
- NCT03058562Study directorPhase 1Feb 1, 2017
- NCT02929264Lead sponsorPhase 1Dec 1, 2016
- NCT02875678Study directorPhase 1Nov 1, 2016
- NCT02875678Lead sponsorPhase 1Nov 1, 2016
Details
- Founded
- Princeton, NJ, US Jun 1, 2011
- Last known activity
- Aug 31, 2018